Total Funding
35
75
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
63789
Avexegen Therapeutics is a biotechnology company developing therapies for gastrointestinal disorders.
- Soumitra Ghosh: Co-Founder and CSOPast Role: Amylin Pharmaceuticals, Executive Director
About the Company
Avexegen Therapeutics develops revolutionary therapies to promote gastro-intestinal health for patients with GI disorders. They offer an approach to directly heal damaged and inflamed gut tissue in patients with crohns disease and ulcerative colitis, as well as in premature infants with necrotizing enterocolitis.
Women Founded
